Source: Health Canada shortage reports · Updated Jul 29, 2026
Some Amitriptyline products are in shortage in Canada (14 of 34 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
A tricyclic antidepressant used to treat depression and nerve pain.
Products affected
14 / 34
In shortage since
Apr 20, 2011
Reports on file
100
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
ELAVIL
50MG · TABLET · AA PHARMA INC
DIN 00335088 · since ?, no end estimate · Disruption of the manufacture of the drug.
Active shortage
ELAVIL
25MG · TABLET · AA PHARMA INC
DIN 00335061 · since ?, no end estimate · Disruption of the manufacture of the drug.
Active shortage
ELAVIL
25MG · TABLET · AA PHARMA INC
DIN 00335061 · since ?, no end estimate · Disruption of the manufacture of the drug.
Active shortage
ELAVIL
10MG · TABLET · AA PHARMA INC
DIN 00335053 · since Nov 29, 2023, no end estimate · Disruption of the manufacture of the drug.
Active shortage
ELAVIL
10MG · TABLET · AA PHARMA INC
DIN 00335053 · since Dec 8, 2023, no end estimate · Disruption of the manufacture of the drug.
Active shortage
JAMP-AMITRIPTYLINE TABLETS
25MG · TABLET · JAMP PHARMA CORPORATION
DIN 02435535 · since Feb 9, 2022, est. end Dec 31, 2023 · Disruption of the manufacture of the drug.
Active shortage
JAMP-AMITRIPTYLINE TABLETS
50MG · TABLET · JAMP PHARMA CORPORATION
DIN 02435543 · since Feb 9, 2022, est. end Dec 31, 2023 · Disruption of the manufacture of the drug.
Active shortage
JAMP-AMITRIPTYLINE TABLETS
50MG · TABLET · JAMP PHARMA CORPORATION
DIN 02435543 · since Feb 9, 2022, est. end Dec 31, 2023 · Disruption of the manufacture of the drug.
Active shortage
JAMP-AMITRIPTYLINE TABLETS
25MG · TABLET · JAMP PHARMA CORPORATION
DIN 02435535 · since Nov 5, 2021, est. end Dec 31, 2023 · Disruption of the manufacture of the drug.
Active shortage
JAMP-AMITRIPTYLINE TABLETS
10MG · TABLET · JAMP PHARMA CORPORATION
DIN 02435527 · since Nov 5, 2021, est. end Dec 31, 2023 · Disruption of the manufacture of the drug.
Active shortage
JAMP-AMITRIPTYLINE TABLETS
10MG · TABLET · JAMP PHARMA CORPORATION
DIN 02435527 · since Nov 5, 2021, est. end Dec 31, 2023 · Disruption of the manufacture of the drug.
Active shortage
JAMP-AMITRIPTYLINE TABLETS
75MG · TABLET · JAMP PHARMA CORPORATION
DIN 02435551 · since Nov 5, 2021, est. end Dec 31, 2023 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Amitriptyline is currently affected by 14 active shortage reports filed with Health Canada by AA PHARMA INC, JAMP PHARMA CORPORATION, BIOMED PHARMA.
The reported causes are: disruption of the manufacture of the drug; dormant; dormant. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Amitriptyline is classified under “ANTIDEPRESSANTS” (ATC N06AA).
Recent changes
Jul 29, 2026
Shortage resolved
Common questions
What is Amitriptyline used for?
A tricyclic antidepressant used to treat depression and nerve pain.
When will Amitriptyline be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Amitriptyline in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.